Feb 27, 2018 06:59 am UTC| Business
CHANDLER, Ariz., Feb. 27, 2018 -- The debugging process remains an important area where many embedded design engineers would like to see improvements, according to AspenCore’s 2017 Embedded Market Study. To...
Global Parental Control Market Will Reach USD 3,300 million by 2025: Zion Market Research
Feb 27, 2018 06:39 am UTC| Business
New York, NY, Feb. 27, 2018 -- Zion Market Research has published a new report titled “Parental Control Market by Deployment Type (On-Premises and Cloud); by Platform Analysis (Windows, Android, IOS, and Others); by...
CGG: Sercel Sells a Sentinel HR High-Resolution Streamer System to German AWI Research Institute
Feb 27, 2018 06:30 am UTC| Business
Sercel Sells a Sentinel HR High-Resolution Streamer System to German AWI Research Institute Paris, France - February 27, 2018 CGG announced today that Sercel has sold one of its new Sentinel® HR high-resolution...
Feb 27, 2018 06:30 am UTC| Business
NANTES, France, Feb. 27, 2018 -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that the first approvals to resume patient accrual in the global Tedopi® Phase 3 trial have been granted in the...
Feb 27, 2018 06:16 am UTC| Business
VANCOUVER, British Columbia, Feb. 26, 2018 -- Global Blockchain Technologies Corp. (the “Company” or “BLOC” or "Global Blockchain") is pleased to provide, due to a high level of investor inquiry, a further detailed...
Basilea reports significantly improved financial results in 2017
Feb 27, 2018 06:16 am UTC| Business
54% increase in total revenue, amounting to CHF 101.5 million Operating loss reduced by 68% to CHF 14.1 million Cash position as of year-end 2017 increased to CHF 310.7 million License and distribution agreements in...
Targovax to present at Biologics World Nordic 2018
Feb 27, 2018 06:01 am UTC| Business
Oslo, Norway, 27 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that the Company will present at the following...